Evaluation of oxypurines by HPLC in lymphoproliferative diseases.
Marinello
E
E
Institute of Biological Chemistry, University of Siena, Italy.
Vannoni
D
D
Porcelli
B
B
Dispensa
E
E
D000328:Adult; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D007042:Hypoxanthines / Q000097:blood* / Q000652:urine; D007938:Leukemia / Q000175:diagnosis / Q000378:metabolism; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000378:metabolism; D008223:Lymphoma / Q000175:diagnosis / Q000378:metabolism; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000378:metabolism; D011379:Prognosis; D011687:Purines / Q000097:blood; D014527:Uric Acid / Q000097:blood* / Q000652:urine; D014970:Xanthines / Q000097:blood* / Q000652:urine
D007042:Hypoxanthines; D011687:Purines; D014970:Xanthines; D014527:Uric Acid